J. Clin. Invest. 1986, 77, 622-630
92 LACOUR B., MASSY Z., JUNGERS P., DRUEKE T.
Anomalies du métabolisme des lipoprotéines
dans l'insuffisance rénale chronique. Néphrologie 1993, 14,
75-90
93 MONNIER L., BARJON J-N., PERCHERON C., COLETTE
C.
Les anomalies lipidiques chez le diabétique. Sang
Thrombose Vaisseaux 1991, 3, 211-220
94 NORDESTGAARD B., TYBJAERG-HANSEN A. IDL, VLDL,
chylomicrons and atherosclerosis. Eur. J. Epidemiol. 1992, 8, Suppl. 1,
92-98
95 DEMACKER P.
Diets and postprandial lipoproteins. Curr. Opin. Lipidol.
1995, 6, 43-47
98 GRUNDY S., VEGA G.
Two different views of the relatioship of
hypertriglyceridemia to coronary heart disease. Arch. Intern. Med. 1992, 152,
28-34
97 ROHEIM P., ASZTALOS B.
Clinical significance of lipoprotein size and risk of
coronary atherosclerosis. Clin. Chem. 1995, 41
98 MEZDOUR H., MONTE G., FRUCHART J-C.
Transfert du cholestérol plasmatique et
athérosclérose. Ann. Biol. Clin. 1994, 52, 95-102
99 TALL A.
Plasma high-density lipoproteins. Metabolism and
relationship to atherogenesis. J. Clin. Invest. 1990, 86, 379-384
100 MOORJANI S., GAGNE C., LUPIEN P., BRUN D.
Plasma triglycerides related decrease in high-density
lipoprotein cholesterol and its association with myocardial infarction in
heterozygous familial hypercholesterolemia.
Metabolism 1986, 35, 311-316
Thèse Docteur Pharmacie La lipoprotéine Lp(a) :
son intérêt dans l'interprétation du bilan lipidique Dr
GUIMONT MC 248/271 Lipides, Lipoprotéine (a),
Hyperlipoprotéinémie, Athérosclérose, Lipids,
Lipoprotein, Lpa, Hyperlipoproteinemia, Atherosclerosis
101 BENDITT E., BENDITT J.
Evidence for a monoclonal origin of human atherosclerotic
plaques. Proc. Natl. Acad. Sci. USA 1973, 70, 1753-1756
102 ONRAED-DUPRIEZ B. Athérosclérose et
oncogènes. Path. Biol. 1992, 40, 56-65
103 BAYAD J., GALTEAU M.M., SIEST G.
Théorie virale de l'athérosclérose.
Place du cytomegalovirus. Ann. Biol. Clin. 1993, 51, 101-107
104 BOERS G.H.J.
The case for mild hyperhomocysteinemia as a risk factor.
J. Inher. Metab. Dis. 1997, 20, 301-306
105 BOUSHEY C.J., BERESFORD S.A., OMENN G.S.
et al
A quantitative assessment of plasma homocysteine as a
risk factor for vascular disease. Probable benefits of increasing folic acid
intakes.
JAMA 1995, 274, 1049-1057
106 SUPERKO H.R.
New aspects of risk factors for the development of
atherosclerosis, including small low-density lipoprotein, homocyst(e)ine, and
lipoprotein(a).
Curr. Opin. Cardiol. 1995, 10, 347-354
107 STEINBERG D.
Metabolism of lipoproteins and their role in the
pathogenesis of atherosclerosis. Atherosclerosis Reviews 1988, 18,
1-23
108 BERG K.,
The Lp system.
Ser. Haematol 1968, 1, 111
109 GAUBATZ J.W., HEIDEMAN
C., GOTTO A.M., MORRISETT J.D., DAHLEN G.H. Human plasma lipoprotein(a).
Structural properties.
J. Biol. Chem. 1983, 258, 4582-4589
110 FLESS G.M., ZUMMALLEN M.E., SCANU A.M. Isolation of
apolipoprotein(a) from lipoprotein(a) J. Lipid Res. 1985, 26,
1224-1229
111 DUBARRY M., MOULLEC J.
Purification d'une fraction de R
lipoprotéine riche en Lp(a). Rev. Fr. Transf. Immunohématol.
1976, 19, 555-562
112 UTERMANN G., WEBER W.
Protein composition of Lp(a) lipoprotein from human
plasma.
FEBS Letters 1983, 154, 357-361
113 ALBERS J., ADOLPHSON J., HAZZARD R.
Radioimmunoassay of human plasma Lp(a) lipoprotein J.
Lipid Res. 1977, 18, 331-338
114 GAUBATZ J.W., CHARI M.V., NAVA M.L., GUYTON J.R.,
MORRISETT J.D. Isolation and characterization of the two major apoproteins in
human lipoprotein(a). J. Lipid Res. 1987, 28, 69-79
Thèse Docteur Pharmacie La lipoprotéine Lp(a) :
son intérêt dans l'interprétation du bilan lipidique Dr
GUIMONT MC 249/271 Lipides, Lipoprotéine (a),
Hyperlipoprotéinémie, Athérosclérose, Lipids,
Lipoprotein, Lpa, Hyperlipoproteinemia, Atherosclerosis
115 ARMSTRONG V.W., WALL! A.K., SEIDEL
D.
Isolation, characterization, and uptake in human
fibroblasts of an apo(a)-free lipoprotein obtained on reduction of
lipoprotein(a).
| 
